KOPRAN LTD

NSE

KOPRAN

Kopran Limited is engaged in pharmaceutical business. The Company's business units include Finished Dosage Forms, Active Pharmaceutical Ingredients, Research and Development, and Consumer Healthcare. It offers its products in therapeutic categories, such as anthelmintic, anti-allergic, antibiotic, cardiovascular, diabetic, gastroenterology, pain and antipyretic, and pain management, among others. The Company's bulk drugs include Atenolol, Amlodipine Besylate, Metoprolol Succinate, Metoprolol Tartrate, Ceftriaxone Sodium Sterile, Doripenem, Tebipenem, Roxithromycin, Rivaroxaban, Zolmitriptan, Azithromycin, Pregabalin, Lymecycline and Nitroxoline. In addition, it offers oral care, lifestyle, beauty and personalized hygiene products. Its manufacturing facility is located at Khopoli, Raigad District, Maharashtra. The Company's subsidiaries include Kopran Research Laboratories Limited, Kopran (H.K) Limited and Kopran Lifesciences Limited.